| Autor: |
Hedström, AK, Alfredsson, L, Lundkvist Ryner, M, Fogdell-Hahn, A, Hillert, Jan, Olsson, T |
| Předmět: |
|
| Zdroj: |
Multiple Sclerosis Journal; Jul2014, Vol. 20 Issue 8, p1081-1085, 5p |
| Abstrakt: |
The article examines how smoking increases the risk of developing antibodies to natalizumab, a biological drug in the treatment of multiple sclerosis (MS). It is said that smoking may lead to the induction of neutralizing antibodies to interferon. The study included 1338 natalizumab-treated MS patients. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
